User menu

Metabolic-activation of Drugs in Mutagenicity Tests Invitro

Bibliographic reference Roberfroid, MB.. Metabolic-activation of Drugs in Mutagenicity Tests Invitro. In: Archives of Toxicology, Vol. 46, no. 1-2, p. 181-193 (1980)
Permanent URL
  1. Batardy-Grégoire M, Razzouk C, Agazzi-Léonard E, Mercier M, Poncelet F, Roberfroid M (1980) In vivo and in vitro effects of 3-méthylcholanthrene on the microsomal mediated in vitro mutagenicity of 2-acetylaminofluorene. Toxicol Lett (in press)
  2. Bartsch H, Malaveille C, Montesano R (1975) Human, rat and mouse liver-mediated mutagenicity of vinyl chloride in S. typhimurium strains. Int J Cancer 15:429?437
  3. Brown JP, Dietrich PS, (1979) Mutagenicity of plant flavonol in the Salmonella/mammalian microsome test. Mutat Res 66:223?240
  4. Buening MK, Fortner JG, Kappas A, Conney AH (1978) 7,8 benzo-flavone stimulates the metabolic activation of aflatoxin B1 to mutagens by human liver. Biochem Biophys Res Commun 82:348?355
  5. Caldwell J (1979) The significance of phase II (conjugation) reactions in drug disposition and toxicity. Life Sci 24:571?578
  6. Conney AH (1967) Pharmacological implications of microsomal enzyme induction. Pharmacol Rev 19:317?366
  7. Connors TA (1976) Bioactivation and cytotoxicity. In: Bridges JW, Chasseaud LF (eds) Progress in drug metabolism. Wiley, London, pp 41?75
  8. Estabrook RW, Linderlab (eds) (1979) The induction of drug metabolism, London (1976). Schattauer, Stuttgart New York
  9. Gatehouse DG, Delow GF (1979) The development of a ?micro-titre®? fluctuation test for the detection of indirect mutagens, and its use in the evaluation of mixed enzyme induction of the liver. Mutat Res 60:239?252
  10. Gorrod JW (1978) The current states of pka concept in the differentiation of enzymic N. oxidation. In: Gorrod JW (ed) Biological oxidation of nitrogen. Elsevier, North Holland, Biomedical Press, Amsterdam New York, pp 201?212
  11. Gutman HR, Erickson RR (1972) The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to 0-amidophenols by rat liver in vitro. J Biol Chem 247:660?666
  12. Hales BT, Jain R (1980) Characteristics of the activation of cyclophosphamide to a mutagen by rat liver. Biochem Pharm 29:256?259
  13. Hutson BH (1975, 1977) Mechanisms of biotransformation. In: Hatway DE (ed) Foreign compound metabolism in mammals, vol 3. The chemical society. London, pp 449?549 and 259?346
  14. Hutton JJ, Meier J, Hackney C (1979a) Comparison of the in vitro mutagenicity and metabolism of dimethylnitrosamine and benzo(a)pyrene in tissues from inbred mice treated with phenobarbital, 3-methylcholanthrene or polychlorinated biphenyls. Mutat Res 66:75?94
  15. Hutton JJ, Hackney C, Meir J (1979b) Mutagenicity and metabolism of dimethylnitrosamine and benzo(a)pyrene in tissue homogenate from inbred syrian hamsters treated with phenobarbital, 3-methylcholanthrene or polychlorinated biphenyls. Mutat Res 64:363?377
  16. IARC (1977) Monographs on the Evaluation of carcinogenic risk of chemicals to man, vol 13. Some Miscellaneous Pharmaceutical Substances
  17. Jacoby WB (1978) The glutathione-S-transferase, a group of multifunctional detoxification proteins. Adv Enzymol 46:384?414
  18. Jenner P, Testa B (1978) Novel pathways in drug metabolism. Xenobiotica 8:1?25
  19. Kadlubar FF, McKee EM, Ziegler DM (1973) Reduced pyridinic nucleotide-dependent N-hydroxyamine oxidase and reductase activities of hepatic microsomes. Arch Biochem Biophys 156:46?57
  20. Kuroki T, Malaveille C, Drevon C, Picolli C, McLeod M, Selkirk J (1979) Critical importance of microsomes concentration in mutagenesis assay with V 79 Chinese hamsters cells. Mutat Res 63:259?272
  21. Levin W, Ryan D, Huang MT, Kawalek J, Thomas PE, West SB, Lu AYH (1977) Characterization of multiple forms of highly purified cytochrome P450 from the liver microsomes of rats, mice and rabbits. In: Ulrich V, Hildebrandt A, Roots I, Estabrook R, Conney AH (eds) Microsomes and drug oxidations. Pergamon Press, Oxford, pp 185?191
  22. Lhoest G, Razzouk C, Mercier (1976) Biological implication of the reaction possibilities of the proximate carcinogenic compound, N-hydroxy-2-fluorenylacetamide. Biomed Mass Spectrom 3:21?27
  23. Lotlikar PD, Miller EC, Miller JA, Margreth A (1965) The enzymatic reduction of the N-hydroxyderivatives of 2-acetylaminofluorene and related carcinogens by tissue preparation. Cancer Res 25:1743?1751
  24. Lu AYH (1976) Liver microsomal drug metabolizing system: Functional components and their properties. Fed Proc 25:2460?2463
  25. Malaveille C, Kuroki T, Brun G, Hautefeuille A, Camus AM, Bartsch H (1970) Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay. Mutat Res 63:245?258
  26. Matsushima T, Jawamura M, Hara K, Sugimura T (1976) A safe substitute for polychlorinated biphenyls as an inducer or metabolic activation system. In: Serres, FJ de, Fouts JR, Bend R, Philpot RM (eds) In vitro metabolic activation in mutagenesis testing. Elsevier, North Holland, Amsterdam New York, pp 85?90
  27. Matsuoka A, Hayashi M, Ishidate M, Jr (1979) Chromosomal aberration tests on 29 chemicals combined with S9 mix in vitro. Mutat Res 66:277?290
  28. Miller EC, Miller JA (1976) The metabolism of chemical carcinogens to reactive electrophiles and their possible mechanisms of action in carcinogenesis. In: Searle CS (ed) Chemical carcinogens. A.C.S. Monograph, vol 173. The American Chemical Society, Washington, pp 727?762
  29. Miller JA (1964) Comments on chemistry of the cycads. Fed Proc 23:1361?1362
  30. Nelson EB, Ras PP, Belfi KJ, Masters BS (1971) Oxidative drug metabolism in human liver microsomes. J Pharmacol Exp Ther 178:580?588
  31. Nelson SD, Timbrell JA, Mitchell JR (1978) Oxidative activation of hydrazines and their hydrazide drug precursor. In: Gorrod JW (ed) Biological oxidation of nitrogen. Elsevier, North Holland, Biomedical Press, Amsterdam New York, pp 295?399
  32. Oesch F (1973) Mammalian epoxide hydratases: Inducible enzymes catalyzing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and oleofinic compounds. Xenobiotica 3:305?340
  33. Oesch F, Bentley P, Glatt HR (1977) Epoxide hydratase: Purification to apparent homogeneity as a specific probe for the relative importance of epoxides among other reactive metabolites. In: Jollow DJ, Kocsis JJ, Snyder R, Vainio H (eds) Biological reactive intermediates. Plenum Press, New York
  34. Ota K, Hammock BD (1980) Cytosolic and microsomal epoxide hydrolases; differential properties in mammalian liver. Science 207:1479?1481
  35. Rannug U, Sandvall A, Ramel C (1978) The mutagenic effect of 1,2-dichloroethane on Salmonella typhimurium. 1. Activation through conjugation with glutathione in vitro. Chem Biol Interact 20:1?16
  36. Razzouk C, Agazzi-Léonard E, Cumps J, Poncelet F, Mercier M, Roberfroid M (1978) Induction, modification and inhibition of rat liver microsomal benzo(a)pyrene hydroxylase; correlation with the S9 mediated mutagenicity of benzo(a)pyrene. Biochem Biophys Res Commun 85:1007?1016
  37. Rosenkranz HS, Speck WT (1978) Mutagenicity of metronidazole: activation by mammalian liver microsomes. Biochem Biophys Res Commun 66:520?525
  38. Rosenkranz HS, Speck WT (1975) Mutagenicity and DNA-modifying activity: A comparison of two microbial assays. Mutat Res 41:61?70
  39. Umeda M, Szito M (1975) Mutagenicity of dimethyl-nitrosamine to mammalian cells as determined by the use of mouse liver microsomes. Mutat Res 30:249?254
  40. Swaminathan S, Lower GM, Jr (1978) Biotransformation and excretion of nitrofurans. Carcinogenesis a comprehensive survey. In: Bryan GT (ed) Nitrofuran, vol 4. Raven Press, New York, pp 59?98
  41. Ziegler DM, Mitchell CH (1972) Microsomal oxidase IV: properties of a mixed function amine oxidase isolated from pig liver microsomes. Arch Biochem Biophys 150:116?125